Portfolio

Williamsburg, Virginia
CEO: Jason McDevitt
Company Status: Private
Investment Status: Current
Fund: GAP BioLife Fund
Drug discovery company with a proprietary and revoluntionary therapeuitc approach for treating anxiety disorders and other afflictions that can benefit from traditional talk therapy treatments.

South Hill, Virginia
CEO: Sherwood H. Creedle
Company Status: Private
Investment Status: Current 
Fund: GAP Tech Fund
Online application that simplifies and automates construction process payments.

Charlottesville, Virginia
CEO: Uday Gupta
Company Status: Private
Investment Status: Current
Fund: GAP Fund I
Low-shear three dimensional cell culturing hardware and growth media.

CEO:Nathan Latka
Company Status: Active
Investment Status: Current
Fund: GAP Tech Fund

CEO: Blake Hall
Company Status: Private
Investment Status: Current
GAP Fund: GAP Tech Fund
Daily deals for vetrans, service members and their immediate families.

Norfolk, Virginia
CEO: Michael Umscheid
Company Status: Private
Investment Status: Current
Fund: GAP Tech Fund
Web-based platform the helps financial institutions comply with increasingly complex reporting requirements.

Sterling, Virginia
CEO: Jeff Conroy
Company Status: Private
Investment Status: Current
Fund: GAP BioLife Fund
Anti-infective small molecule drug discovery and development company searching for new anti-microbial drugs targeting bacterial toxins.

Sterling, Virginia
CEO: Jody Glidden
Company Status: Private
Investment Status: Current
GAP Fund: GAP Tech Fund
Social media tool designed to increase sales force productiviy, leveraging social connections of company's employees to drive warm introductions and leads for sales reps.

Fairfax, Virginia
CEO: Anup Ghosh 
Company Status: Private
Investment Status: Current 
GAP Fund:GAP Tech Fund
Invincea is the first and only fully virtualized browser solution that seamlessly runs your browser in its own virtual environment separate from the desktop operating system to protect users against all types of Web-borne threats.

Charlottesville, Virginia
CEO: Greg Fralish
Company Status: Private
Investment Status: Current
GAP Fund: GAP Tech Fund
Developer of proprietary technology that identifies a protein biomarker in the early stages of pancreatic cancer.